Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder
Megan Kinzel, Amit Kalra, Rutvij A. Khanolkar, Tyler Williamson, Na Li, Faisal M. Khan, Robert Puckrin, Peter Duggan, Mona Shafey, Jan Storek
Topics & Concepts
RituximabMedicineNeutropeniaHypogammaglobulinemiaPost-transplant lymphoproliferative disorderInternal medicineGastroenterologyTransplantationLymphoproliferative disordersImmunosuppressionImmunologyHematopoietic stem cell transplantationIncidence (geometry)ToxicityLymphomaAntibodyOpticsPhysicsHematopoietic Stem Cell TransplantationViral-associated cancers and disordersPolyomavirus and related diseases